Mitokyne Garners $45,000,000 Series A Financing Round

  • Feed Type
  • Date
    10/21/2013
  • Company Name
    Mitokyne
  • Mailing Address
    Undisclosed Boston, MA 02109
  • Company Description
    Mitokyne is a biotech company focused on mitochondria-related drug discovery and development. The company is utilizing its innovative screening platform to identify and develop novel drugs that improve mitochondria function and provide treatments for genetic, metabolic and neurodegenerative disorders as well as diseases and conditions of aging.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $45,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Astellas Venture Capital
  • Venture Investor
    MPM Capital
  • Venture Investor
    Longwood Founders Fund

By posting a comment, you agree to our terms and conditions.